Details, Fiction and who makes copyright semaglutide
In March 2025, the company introduced new plans for any direct-to-shopper offering of its Wegovy weight loss drug. The company recognized a completely new pharmacy, referred to as NovoCare, which would charge customers $499 per month for entry to the drug, less than 50 % the cost of the drug by means of other pharmaceutical distribution networks.[5